Andrew J Klink, PhD, MPH

Research Reports

KRAS/RAS Testing Is Associated With Reduced Risk of Treatment Discontinuation in Patients With Metastatic Colorectal Cancer

08/22/2018

Alexandra Christodoulopoulou, MSc

Bruce A Bach, MD, PhD

Andrew J Klink, PhD, MPH

Guy Hechmati, MD, MSc

Urvi Mujumdar, MPH

Bruce A Feinberg, DO

Marwan Fakih, MD

Abstract: Current clinical guidelines recommend that all patients with metastatic colorectal cancer (mCRC) have tumor tissue genotyped for RAS mutations. This study aimed to evaluate patient characteristics and...

...

08/22/2018

Journal of Clinical Pathways

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

September 18 ⁠–⁠ September 20

September 20 ⁠–⁠ September 22

September 21 ⁠–⁠ September 22

September 30 ⁠–⁠ October 2

October 1 ⁠–⁠ October 2

October 2 ⁠–⁠ October 5

October 5 ⁠–⁠ October 6

October 14 ⁠–⁠ October 16

October 16 ⁠–⁠ October 19

October 19 ⁠–⁠ October 20

See Full Calendar

Andrew J Klink, PhD, MPH

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products